Prescription Drug Rebate Reform Act of 2019

United States116th CongressHR-3805House of Representatives
Updated: Jul 18, 2019

Summary

Prescription Drug Rebate Reform Act of 2019 This bill requires private health insurance plans to set any coinsurance rate for a covered prescription drug based on the net price of the drug (the price after accounting for rebates and discounts provided by the drug manufacturer) and not the list price (the initial wholesale price set by the drug manufacturer). This requirement applies when a plan holder has an unmet deductible or other coinsurance obligation for prescription drug benefits under the plan. The bill does not prohibit a plan from requiring a copayment provided that such copayment is not based on the cost of the drug.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-1384: Prescription Drug Rebate Reform Act of 2019

Introduced in Senate

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.